OSE Immunotherapeutics (XPAR:OSE) Price-to-Operating-Cash-Flow : (As of May. 31, 2024)

View and export this data going back to 2015. Start your Free Trial

What is OSE Immunotherapeutics Price-to-Operating-Cash-Flow?

As of today (2024-05-31), OSE Immunotherapeutics's share price is €8.29. OSE Immunotherapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.02. Hence, OSE Immunotherapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for OSE Immunotherapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 12 years, OSE Immunotherapeutics's highest Price-to-Operating-Cash-Flow Ratio was 148.20. The lowest was 5.46. And the median was 50.07.

XPAR:OSE's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.32
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

OSE Immunotherapeutics's Cash Flow from Operations per share for the six months ended in Dec. 2023 was €-0.39. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 7.00% per year.

During the past 12 years, OSE Immunotherapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 130.60% per year. The lowest was -39.60% per year. And the median was -31.00% per year.

OSE Immunotherapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for OSE Immunotherapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OSE Immunotherapeutics Price-to-Operating-Cash-Flow Chart

OSE Immunotherapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

6.04

OSE Immunotherapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of OSE Immunotherapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, OSE Immunotherapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OSE Immunotherapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OSE Immunotherapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where OSE Immunotherapeutics's Price-to-Operating-Cash-Flow falls into.

OSE Immunotherapeutics Price-to-Operating-Cash-Flow Calculation

OSE Immunotherapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	8.29	/	-1.022
	=

OSE Immunotherapeutics's Share Price of today is €8.29.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. OSE Immunotherapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-1.02.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

OSE Immunotherapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of OSE Immunotherapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

OSE Immunotherapeutics (XPAR:OSE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (XPAR:OSE) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

6OP:Germany

Address

22, Boulevard Benoni Goullin, Nantes, FRA, 44200

Website

http://www.ose-immuno.com

OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.

OSE Immunotherapeutics (XPAR:OSE) Headlines

No Headlines